In @CIDJournal, @JessicaLittleMD and colleagues evaluate the immunologic, virologic, and clinical outcomes of dual/extended antiviral therapy in severely immunocompromised patients with protracted SARS-CoV-2 infection. https://t.co/m39p773Vwh
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on Histoplasmosis: Treatment of Asymptomatic Histoplasma Pulmonary Nodules
https://t.co/hnC1Khu9Qh
Checkout our viewpoint!
TLDR; PCT guided strategies in sepsis should focus on antibiotic discontinuation, but its real benefit may be in early application in the ED to support diagnostic reasoning, triage, and stewardship.
Reassessing Procalcitonin-Guided Antibiotic Therapy in Critically Ill Patients with Sepsis: Lessons from the ADAPT-Sepsis Trial
✅ Just Accepted
🔗 https://t.co/GcJpZfAoZZ
Out now! Our review on Jaw Osteomyelitis 💀���
An honor to have paired with expert in the field of head/neck infections and outstanding mentor Dr. Miriam Barshak for this one!
https://t.co/aTehGiRK6U
Excited to share our research on Cocci antifungal ppx in SOT!
TLDR; For patients repeatedly pos for EIA-IgM-only w no seroconversion, compatible clinical illness, or rads findings, discontinuing antifungal ppx may be reasonable after 1st posttxp yr
https://t.co/T1Yqs9SklQ
Initial micafungin treatment does not improve outcomes compared to fluconazole treatment in immunocompromised and critically ill patients with candidaemia - Challenges the dogma. #IDWeek2024 https://t.co/yla60J8MDl
Oropouche virus, which causes a dengue-like illness, is spreading across regions of Latin America & the Caribbean.
Our study identifies the likely locations where travelers may present with this infection upon returning from these areas.
https://t.co/xFvvABpfrf in @jtravmed.